• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Insurance Issues in Psychiatry

Insurance Issues in Psychiatry

April 1, 2009
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

TCPR: Psychiatric treatment has been discriminated against by insurance companies for years. The recent passage of historic parity legislation may change this. Can you bring us up to speed on the history of this difficult relationship between insurance companies and psychiatrists? 

Dr. Sharfstein: The first problem is that when insurance was invented in the U.S. in the 1930s, psychiatric care was excluded. Why? Principally because there was a state hospital system. The presence of the public sector meant to employers and others that there was someone else to foot the bill. That has been obstacle number one, and it has never entirely gone away.

TCPR: How does this still play out?Dr. Sharfstein: Take HMOs, for example, where the tradition has been a 20 visit maximum. Why? The insurance companies seemed to think that if more than 20 visits were needed, the patient belonged in a state hospital.The second historical problem is typified by the experience of the Actors Equity union in New York, which, in the 1950s, provided comprehensive mental health insurance. It covered all outpatient services including psychoanalysis, and every actor went into psychoanalysis. The plan went broke in no time flat. This entered the lore among insurance carriers, and they became convinced that you could not cover outpatient mental health because it was very costly, you couldn’t decide who needed it, and there was no way to manage the benefits.

TCPR: Given these obstacles, what led to the passage of parity legislation?

Dr. Sharfstein: Well, there was a 25 year effort to get the parity act passed. It’s now called the Domenici Wellstone Parity Mental Health and Substance Abuse Nondiscrimination Act. It’s clear that mental health benefits can be managed properly; the Federal Employees Benefit Program has been a kind of national model.

TCPR: Wasn’t there a parity act passed 10 years ago?

Dr. Sharfstein: Yes, it was a kind of forerunner of the current one, but it was weak. It required parity for annual limits and lifetime limits, but within that you could have higher copayments and higher deductibles for mental health, and most companies added these limits. Thiscurrentparitybillwon’tlet that happen. So this means that not only annual and lifetime limits, but also copayments, coinsurance, deductibles, and out of pocket expenses can’t be any more restrictive than those for medical and surgical services.

TCPR: Is this the big fix that you think we need?

Dr. Sharfstein: I think it is very helpful, but it is not necessarily the big fix for a couple of reasons. The act allows companies to exclude specific diagnoses, and the one they really want to exclude is substance abuse treatment, which doesn’t make a lot of sense, since the bill itself is called the Mental Health and Substance Use Nondiscrimination Act. The other concern is that insurance plans may drop mental health coverage altogether to avoid having to pay for parity, but I think this would be hard to do politically.

TCPR: Will the parity bill have any effect on reimbursement rates for psychiatrists?

Dr. Sharfstein: Probably not, and this is a problem, because currently about 50% of U.S. psychiatrists do not participate in any insurance, because the fees they pay are very low. And psychiatrists have found that there is a large group of people who are willing to pay out of pocket and so they don’t have to deal with these fee restrictions, nor do they have to deal with the insurance paperwork and phone calls. Another advantage is that patients can be assured of confidentiality, since without insurance there is no need to write treatment reports that go into a file somewhere and may be seen by the wrong eyes. 

TCPR: Why do insurance companies undervalue the work that psychiatrists do as therapists?

Dr. Sharfstein: There are several reasons. One is the overall devaluation of mental health care because of stigma. But the issue of psychiatrists doing psychotherapy is an economic one. There are plenty of psychologists and social workers out there who are very happy with the fees paid by insurance companies.

TCPR: But wouldn’t psychiatrists argue that they can provide better treatment?

Dr. Sharfstein: Yes, and we do. We have the medical training, and therefore we can provide both the medication and the therapy treatment. We certainly can manage very difficult patients better than others. I think that smart consumers want to go to the best trained and most competent people especially when it comes to serious life-threatening illnesses such as severe depression, borderline personality disorder, and severe anxiety disorders. Because of this, psychiatrists do very well attracting cash patients.

TCPR: Are psychiatrists going to get bad PR for being the only specialty that doesn’t like to take insurance?

Dr. Sharfstein: First of all, it is not just psychiatry. There is a growing movement among primary care doctors who are starting concierge practices that charge patients a yearly out of pocket fee for all their care. But that said, yes, I think this trend does create problems because the big insurance systems can’t find psychiatrists for their panels, and that makes them angry. If the insurance companies raised their fees and hassled less, they would have more psychiatrists willing to participate.

General Psychiatry
    www.thecarlatreport.com
    Issue Date: April 1, 2009
    SUBSCRIBE NOW
    Table Of Contents
    Small Efficacy Differences Between Atypicals in Treating Schizophrenia
    Unclear Relationship Between SSRI Use and Gestational Hypertension
    Lamictal May Have Small Benefit for Bipolar Depression
    Health Care Reform: A Primer
    Insurance Issues in Psychiatry
    Monitoring Adverse Effects of Medications
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.